ARCHIVES

Novartis Begins Study Of Femara And Zometa In Postmenopausal Early Breast Cancer

This article is from The Cancer Letter archive.

Vol. 25 No. 12 | December 27, 2002

Download PDF Visit The Full Archive

Related Articles

Shubik Named To Another NCA Term In Surprise Move

June 25, 1976

Weak Electromagnetic Fields Can Possibly Stabilize Tumors

September 30, 2011

NCCS Networker Volume 11 Issue 1, Spring 1997 Special Report: The Cancer Bill

April 13, 1997

In Brief: Issell To Retire As Hawaii Center Director; M.D. Anderson honors LeMaistre, Faculty

November 8, 1996

Feinstein Introduces New Cancer Act; Groups Say Bill Flawed

March 15, 2002

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014